Evidence map›Paper›PMID 25171508›Full record

ArticleInflammatory bowel diseases2014

Mucosal transcriptomics implicates under expression of BRINP3 in the pathogenesis of ulcerative colitis.

Philip J Smith, Adam P Levine, Jenny Dunne, Paul Guilhamon, Mark Turmaine, Gavin W Sewell, Nuala R OʼShea, Roser Vega, Jennifer C Paterson, Dahmane Oukrif and 6 more

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in Inflammatory bowel diseases, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Integrative Analysis of Intestinal Transcriptomes UnderscoresBioinformatics and biology insights · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

  • Erratum issued
  • Erratum issued
5 · Who and what money

Authors and funding

16 authors at 3 institutions in 1 country.

Philip J Smith*Centre for Molecular Medicine, Division of Medicine, University College London, London, United Kingdom; †Department of Gastroenterology, University College London Hospitals NHS Foundation Trust, London, United Kingdom; ‡Medical Genomics, UCL Cancer Institute, University College London, London, United Kingdom; §Division of Bioscience, University College London, London, United Kingdom; ‖Research Pathology and Advanced Diagnostics, UCL Cancer Institute, University College London, London, United Kingdom; and ¶Microbial Diseases, Eastman Dental Institute, University College London, London, United Kingdom.
Adam P Levine
Jenny Dunne
Paul Guilhamon
Mark Turmaine
Gavin W Sewell
Nuala R OʼShea
Roser Vega
Jennifer C Paterson
Dahmane Oukrif
Stephan Beck
Stuart L Bloom
Marco Novelli
Manuel Rodriguez-Justo
Andrew M Smith
Anthony W Segal
University College London · GBUniversity College London Hospitals NHS Foundation Trust · GBEastman Dental Hospital · GB

Funding

Medical Research Council G0902005Medical Research Council G0902022Medical Research Council MR/L000261/1Wellcome Trust 074816Wellcome Trust 081731Wellcome Trust 088683
6 · The paper itself

Abstract

backgroundMucosal abnormalities are potentially important in the primary pathogenesis of ulcerative colitis (UC). We investigated the mucosal transcriptomic expression profiles of biopsies from patients with UC and healthy controls, taken from macroscopically noninflamed tissue from the terminal ileum and 3 colonic locations with the objective of identifying abnormal molecules that might be involved in disease development.

methodsWhole-genome transcriptional analysis was performed on intestinal biopsies taken from 24 patients with UC, 26 healthy controls, and 14 patients with Crohn's disease. Differential gene expression analysis was performed at each tissue location separately, and results were then meta-analyzed. Significantly, differentially expressed genes were validated using quantitative polymerase chain reaction. The location of gene expression within the colon was determined using immunohistochemistry, subcellular fractionation, electron and confocal microscopy. DNA methylation was quantified by pyrosequencing.

resultsOnly 4 probes were abnormally expressed throughout the colon in patients with UC with Bone morphogenetic protein/Retinoic acid Inducible Neural-specific 3 (BRINP3) being the most significantly underexpressed. Attenuated expression of BRINP3 in UC was independent of current inflammation, unrelated to phenotype or treatment, and remained low at rebiopsy an average of 22 months later. BRINP3 is localized to the brush border of the colonic epithelium and expression is influenced by DNA methylation within its promoter.

conclusionsGenome-wide expression analysis of noninflamed mucosal biopsies from patients with UC identified BRINP3 as significantly underexpressed throughout the colon in a large subset of patients with UC. Low levels of this gene could predispose or contribute to the maintenance of the characteristic mucosal inflammation seen in this condition.

Indexed as

Gene Expression ProfilingAdolescentAdultAgedBiomarkersBlotting, WesternCase-Control StudiesColitis, UlcerativeCrohn DiseaseDNA-Binding ProteinsFemaleFollow-Up StudiesHumansImmunoenzyme TechniquesIntestinal MucosaMaleBiomarkersBRINP3 protein, humanDNA-Binding ProteinsRNA, Messenger

Identifiers

PMID25171508
PMCPMC4531309
OpenAlexW2094268729

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.